Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 June 2022 | Story Andre Damons | Photo Reuben Maeko
Dr Nicholas Pearce, Head of the Department of General Surgery in the Faculty of Health Sciences at the University of the Free State (UFS), shows off his new socks with some of the students who came out to celebrate the day.

The high-pressure nature of working in the health sector and some of the conditions under which doctors have to work and to which they are exposed not only make them vulnerable, but it might have an effect on their mental state. 

It is for this reason that the Faculty of Health Sciences at the University of the Free State (UFS) celebrates the
CrazySocks4Docs campaign each year. In order to create awareness on the importance of medical students’ mental health, Investec once again sponsored crazy socks for our undergraduate medical students this year, after a very successful CrazySocks4Docs Day in 2021. 

Crazy Socks for Docs was created in 2017 by Victorian doctor Geoff Toogood, who has a lived experience of depression and anxiety. 

After wearing odd socks to work one day, Dr Toogood found that people were talking behind his back and questioning his mental health. The reality was that his new puppy ate his socks, but he was struck by the stigma and discrimination still associated with mental health and well-being.

Angie Vorster, Clinical Psychologist from the School of Medicine in the Faculty of Health Sciences, says students and staff were encouraged to wear mismatched, colourful, crazy socks on 3 June 2022 in order to draw attention to the mental health and well-being of our medical students and medical doctors – who have carried us through more than two years of a pandemic. 

“The more we speak about mental health and change the narrative around mental illness as normal life experiences, the better we are able to reduce stigma and increase help-seeking behaviour among our healthcare professionals,” says Vorster.

Head of Surgery, Dr Nicholas Pearce; Acting Head of the School of Clinical Medicine, Prof Hanneke Brits; the Programme Director of the Undergraduate School of Clinical Medicine, Dr Yolandi Swart; and Arishka Kalicharan, the Phase I Chairperson, along with the School of Clinical Medicine's Clinical Psychologist, Angie Vorster, came to celebrate their socks with medical students. 

“The students took a break from studying for their exams to have some fun. Even though it was freezing outside, our toes were as warm as our hearts. A great big word of thanks to Investec for caring about our students' mental health and always supporting our endeavours in the Faculty of Health Sciences. It takes a village to train a doctor!’

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept